|
|
Blood, 1 June 2007, Vol. 109, No. 11, pp. 4753-4760.
Prepublished online as a Blood First Edition Paper on February 20, 2007; DOI 10.1182/blood-2006-12-063933.
Previous Article | Next Article 
Submitted December 21, 2006
Accepted February 6, 2007
Inhibition of Dll4 mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion
Jeffrey S Scehnet, Weidong Jiang, S Ram Kumar, Valery Krasnoperov, Alexandre Trindade, Rui Benedito, Dusan Djokovic, Cristina Borges, Eric J Ley, Antonio Duarte, and Parkash S Gill*
Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, United States
Vasgene Therapeutics, Los Angeles, CA, United States
Department of Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, United States
CIISA, Faculdade de Medicina Veterinaria, Technical University of Lisbon, Lisbon, Portugal
Instituto Gulbenkian de Ciencia, Oeiras, Portugal
Department of Colorectal Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, United States
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, United States
* Corresponding author; email: parkashg{at}usc.edu.
Vascular development is dependent on various growth factors and certain modifiers critical for providing arterial or venous identity, interaction with the surrounding stroma and tissues, hierarchical network formation, and recruitment of pericytes. Notch receptors and ligands (Jagged and Delta-like) play a critical role in this process in addition to VEGF. Dll4 is one of the Notch ligands that regulate arterial specification and maturation events. In the current study, we have shown that loss of function by either targeted allele deletion or use of a soluble form of Dll4 extracellular domain leads to inhibition of Notch signaling, resulting in increased vascular proliferation but defective maturation. Newly forming vessels have thin caliber, a markedly reduced vessel lumen, markedly reduced pericyte recruitment and deficient vascular perfusion. sDll4 similarly induced defective vascular response in tumor implants leading to reduced tumor growth. Interference with Dll4-Notch signaling may be particularly desirable in tumors which have highly induced Dll4-Notch pathway.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.-T. Huang, Y.-S. Dai, Y.-B. Chou, Y.-H. Juan, C.-C. Wang, and B.-L. Chiang
Regulatory T Cells Negatively Regulate Neovasculature of Airway Remodeling via DLL4-Notch Signaling
J. Immunol.,
October 1, 2009;
183(7):
4745 - 4754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rauen, U. Raffetseder, B. C. Frye, S. Djudjaj, P. J. T. Muhlenberg, F. Eitner, U. Lendahl, J. Bernhagen, S. Dooley, and P. R. Mertens
YB-1 Acts as a Ligand for Notch-3 Receptors and Modulates Receptor Activation
J. Biol. Chem.,
September 25, 2009;
284(39):
26928 - 26940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Skuli, L. Liu, A. Runge, T. Wang, L. Yuan, S. Patel, L. Iruela-Arispe, M. C. Simon, and B. Keith
Endothelial deletion of hypoxia-inducible factor-2{alpha} (HIF-2{alpha}) alters vascular function and tumor angiogenesis
Blood,
July 9, 2009;
114(2):
469 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cullion, K. M. Draheim, N. Hermance, J. Tammam, V. M. Sharma, C. Ware, G. Nikov, V. Krishnamoorthy, P. K. Majumder, and M. A. Kelliher
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
Blood,
June 11, 2009;
113(24):
6172 - 6181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kokai, F. Voss, F. Fleischer, S. Kempe, D. Marinkovic, H. Wolburg, F. Leithauser, V. Schmidt, U. Deutsch, and T. Wirth
Myc Regulates Embryonic Vascular Permeability and Remodeling
Circ. Res.,
May 22, 2009;
104(10):
1151 - 1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamanda, S. Ebihara, M. Asada, T. Okazaki, K. Niu, T. Ebihara, A. Koyanagi, N. Yamaguchi, H. Yagita, and H. Arai
Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade
Blood,
April 9, 2009;
113(15):
3631 - 3639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Pina, H. Boutrid, A. Schefler, S. Dubovy, W. Feuer, M.-E. Jockovich, and T. G. Murray
Blood Vessel Maturation in Retinoblastoma Tumors: Spatial Distribution of Neovessels and Mature Vessels and Its Impact on Ocular Treatment
Invest. Ophthalmol. Vis. Sci.,
March 1, 2009;
50(3):
1020 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Indraccolo, S. Minuzzo, M. Masiero, I. Pusceddu, L. Persano, L. Moserle, A. Reboldi, E. Favaro, M. Mecarozzi, G. Di Mario, et al.
Cross-talk between Tumor and Endothelial Cells Involving the Notch3-Dll4 Interaction Marks Escape from Tumor Dormancy
Cancer Res.,
February 15, 2009;
69(4):
1314 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Duarte, V. Kolev, D. Kacer, C. Mouta-Bellum, R. Soldi, I. Graziani, A. Kirov, R. Friesel, L. Liaw, D. Small, et al.
Novel Cross-Talk between Three Cardiovascular Regulators: Thrombin Cleavage Fragment of Jagged1 Induces Fibroblast Growth Factor 1 Expression and Release
Mol. Biol. Cell,
November 1, 2008;
19(11):
4863 - 4874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Trindade, S. Ram Kumar, J. S. Scehnet, L. Lopes-da-Costa, J. Becker, W. Jiang, R. Liu, P. S. Gill, and A. Duarte
Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos
Blood,
September 1, 2008;
112(5):
1720 - 1729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Segarra, C. K. Williams, M. d. l. L. Sierra, M. Bernardo, P. J. McCormick, D. Maric, C. Regino, P. Choyke, and G. Tosato
Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth
Blood,
September 1, 2008;
112(5):
1904 - 1911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hayashi, H. Sano, S. Seo, and T. Kume
The Foxc2 Transcription Factor Regulates Angiogenesis via Induction of Integrin {beta}3 Expression
J. Biol. Chem.,
August 29, 2008;
283(35):
23791 - 23800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Williams, M. Segarra, M. De La Luz Sierra, R. C.A. Sainson, G. Tosato, and A. L. Harris
Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells
Cancer Res.,
March 15, 2008;
68(6):
1889 - 1895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yan and G. D. Plowman
Delta-like 4/Notch Signaling and Its Therapeutic Implications
Clin. Cancer Res.,
December 15, 2007;
13(24):
7243 - 7246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Li, R. C.A. Sainson, W. Shi, R. Leek, L. S. Harrington, M. Preusser, S. Biswas, H. Turley, E. Heikamp, J. A. Hainfellner, et al.
Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
Cancer Res.,
December 1, 2007;
67(23):
11244 - 11253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Roca and R. H. Adams
Regulation of vascular morphogenesis by Notch signaling
Genes & Dev.,
October 15, 2007;
21(20):
2511 - 2524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gridley
Notch signaling in vascular development and physiology
Development,
August 1, 2007;
134(15):
2709 - 2718.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|